Insurance coverage for GLP-1 weight-management medication is wider in 2026 than it was in 2024 but still very far from automatic. Here is what actually moves a claim from denial to approval, and which providers will navigate the paperwork on your behalf.
The 2026 picture
Across employer-sponsored plans the coverage picture has improved meaningfully: roughly 45% of large-employer plans now cover at least one branded GLP-1 for weight loss, up from roughly 25% two years ago. Coverage on individual marketplace plans remains narrower, and Medicare coverage for weight-loss-only indications remains restricted.
Coverage by plan type
- Large-employer commercial plans: coverage is the most common here, usually with prior authorization. Wegovy and Zepbound are both routinely covered.
- Small-employer commercial plans: coverage is hit or miss; check the formulary.
- ACA marketplace plans: uncommon. A subset of plans cover with prior auth; many exclude weight-management indications entirely.
- Medicare: covers GLP-1 for diabetes (Ozempic, Mounjaro) but not for weight-management-only indications (Wegovy, Zepbound) without comorbidity rationale.
- Medicaid: highly state-dependent.
Check your formulary directly — the insurer’s member portal will show whether Wegovy or Zepbound is “covered,” “not covered,” or “covered with prior authorization.”
Documentation that flips a denial
If your plan covers GLP-1 with prior authorization, the package that gets approved usually includes:
- Documented BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity.
- Evidence of a prior structured weight-loss attempt (often 6 months) — diet program, prior medication, lifestyle program.
- Recent labs: A1C, lipid panel, basic metabolic panel.
- Prescriber documentation of medical necessity, not “patient request.”
The single most common reason for denial is missing the “prior weight-loss attempt” requirement. WeightWatchers, Noom, and Found all generate documentation that satisfies this for most plans.
Providers that handle paperwork
If you do not want to navigate the paperwork yourself, three telehealth providers in our 2026 ranking handle prior-authorization in-house:
- Ro Body Program — full prior-auth team, branded medication focus.
- Sequence (WeightWatchers Clinic) — insurance-coordinated workflow built around branded GLP-1.
- Form Health — physician-led, accepts most major insurers, slower start but thorough.
Appealing a denial
A first-pass denial is common and reversible. The standard appeal includes:
- A clinician-written letter of medical necessity referencing your specific BMI, comorbidities, and prior attempts.
- Updated labs supporting the medical-necessity case.
- Citation of the FDA-approved indication for your specific medication.
Roughly half of well-prepared first appeals succeed. If your appeal is denied a second time, you can request an independent external review — your state insurance commissioner’s office can guide this.